Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Dana Farber Cancer Inst
Boston, Massachusetts
The records below are financial disclosure and conflict of interest records obtained by ProPublica from the National Institutes of Health and dozens of large public universities across the country. The NIH only has records for researchers who seek or receive its funding.
Total Disclosures: 136
| Name | Type | Company | Disclosed Value | Year Filed |
|---|---|---|---|---|
| Richard Young | Conflict of Interest | Syros Pharmaceuticals | >$600,000 | 2017 |
| Levi Garraway | Conflict of Interest | Foundation Medicine | >$600,000 | 2013 |
| Joel Linden | Conflict of Interest | Adenosine Therapeutcis | >$600,000 | 2015 |
| Catherine Wu | Conflict of Interest | Neon Therapeutics, Inc. | >$600,000 | 2018 |
| Nathanael Gray | Conflict of Interest | Syros Pharmaceuticals | >$600,000 | 2019 |
| Levi Garraway | Conflict of Interest | Foundation Medicine | >$600,000 | 2014 |
| Catherine Wu | Conflict of Interest | Neon Therapeutics | >$600,000 | 2019 |
| Levi Garraway | Conflict of Interest | Foundation Medicine | >$600,000 | 2014 |
| Jae Keith Joung | Conflict of Interest | Editas Medicine | >$600,000 | 2017 |
| Richard Young | Conflict of Interest | Syros Pharmaceuticals | >$600,000 | 2017 |
| Todd Golub | Conflict of Interest | Foundation Medicine | $300,000 - $349,999 | 2013 |
| Cigall Kadoch | Conflict of Interest | Foghorn Therapeutics | $200,000 - $249,999 | 2019 |
| Cigall Kadoch | Conflict of Interest | Foghorn Therapeutics | $200,000 - $249,999 | 2019 |
| Donald Kufe | Conflict of Interest | Genus Oncology | $150,000 - $199,999 | 2013 |
| Donald Kufe | Conflict of Interest | Genus Oncology | $150,000 - $199,999 | 2017 |
| Donald Kufe | Conflict of Interest | Genus Oncology | $150,000 - $199,999 | 2017 |
| Cigall Kadoch | Conflict of Interest | Foghorn Therapeutics | $150,000 - $199,999 | 2018 |
| Donald Kufe | Conflict of Interest | Genus Oncology | $150,000 - $199,999 | 2013 |
| Angelo Volandes | Conflict of Interest | ACP Decisions Nous | $150,000 - $199,999 | 2018 |
| Cigall Kadoch | Conflict of Interest | Foghorn Therapeutics | $150,000 - $199,999 | 2018 |
| Cigall Kadoch | Conflict of Interest | Foghorn Therapeutics, Inc. | $150,000 - $199,999 | 2017 |
| Loren Walensky | Conflict of Interest | Aileron Therapeutics | $150,000 - $199,999 | 2017 |
| James Bradner | Conflict of Interest | Tensha Therapeutics | $100,000 - $149,999 | 2013 |
| Donald Kufe | Conflict of Interest | Genus Oncology | $100,000 - $149,999 | 2018 |
| Richard Young | Conflict of Interest | Syros Pharmaceuticals | $100,000 - $149,999 | 2017 |
| Catherine Wu | Conflict of Interest | Neon Therapuetics | $100,000 - $149,999 | 2017 |
| Richard Young | Conflict of Interest | Syros Pharmaceuticals | $100,000 - $149,999 | 2017 |
| Catherine Wu | Conflict of Interest | Neon Therapeutics, Inc. | $100,000 - $149,999 | 2018 |
| Donald Kufe | Conflict of Interest | Genus Oncology | $100,000 - $149,999 | 2018 |
| Donald Kufe | Conflict of Interest | Genus Oncology | $100,000 - $149,999 | 2018 |
| Bruce Spiegelman | Conflict of Interest | Calico | $100,000 - $149,999 | 2017 |
| Jae Keith Joung | Conflict of Interest | Editas Medicine | $100,000 - $149,999 | 2017 |
| Catherine Wu | Conflict of Interest | Neon Therapeutics | $100,000 - $149,999 | 2017 |
| Nathanael Gray | Conflict of Interest | C4 Therapeutics | $80,000 - $99,999 | 2018 |
| Nathanael Gray | Conflict of Interest | C4 Therapuetics | $80,000 - $99,999 | 2017 |
| Levi Garraway | Conflict of Interest | Foundation Medicine | $80,000 - $99,999 | 2013 |
| Nathanael Gray | Conflict of Interest | C4 Therapeutics | $80,000 - $99,999 | 2018 |
| Levi Garraway | Conflict of Interest | Foundation Medicine | $60,000 - $79,999 | 2014 |
| Nathanael Gray | Conflict of Interest | Syros Pharmaceuticals | $60,000 - $79,999 | 2019 |
| Levi Garraway | Conflict of Interest | Foundation Medicine | $60,000 - $79,999 | 2014 |
| Kenneth Anderson | Conflict of Interest | Acetylon Pharmaceuticals | $60,000 - $79,999 | 2015 |
| Nathanael Gray | Conflict of Interest | Petra Pharmaceuticals | $60,000 - $79,999 | 2018 |
| Nathanael Gray | Conflict of Interest | Syros Pharmaceuticals | $60,000 - $79,999 | 2017 |
| Todd Golub | Conflict of Interest | Foundation Medicine | $60,000 - $79,999 | 2013 |
| Teru Hideshima | Conflict of Interest | Acetylon Pharmaceuticals | $60,000 - $79,999 | 2015 |
| Dharminder Chauhan | Conflict of Interest | Stemline Therapeutics | $40,000 - $59,999 | 2018 |
| Ralph Mazitschek | Conflict of Interest | Acetylon Pharmaceuticals | $40,000 - $59,999 | 2015 |
| Angelo Volandes | Conflict of Interest | ACP Decisions Nous | $40,000 - $59,999 | 2018 |
| Catherine Wu | Conflict of Interest | Neon Therapeutics | $40,000 - $59,999 | 2019 |
| David Scadden | Conflict of Interest | Agios Pharmaceuticals | $40,000 - $59,999 | 2019 |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.